본문 바로가기

Incidence and Risk Factors of Recurrent Anterior Uveitis in Initial Acute-Onset Vogt-Koyanagi-Harada Disease

문서 유형
연구출판물 · 학술지 논문
등재
KCIScopus
저널 순위
Scopus Q3KCI Q3
저널
Korean Journal of Ophthalmology37(4) · pp.299 · 2023
피인용
Scopus 0KCI 0
FWCI (Scopus)
0
ISSN
1011-8942

저자

  1. Lim, Yeon Ju제1저자Department of Ophthalmology, Haeundae Paik Hospital, College of Medicine, Inje University, Busan, Korea
  2. 변익수Department of Ophthalmology, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea
  3. Kim, Hyun WoongDepartment of Ophthalmology, Haeundae Paik Hospital, College of Medicine, Inje University, Busan, Korea
  4. 박성후Department of Ophthalmology, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea
  5. 권한조Department of Ophthalmology, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea
  6. 김은아교신저자Department of Ophthalmology, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea

초록

Purpose: We report the estimated incidence of, and risk factors for, recurrent anterior uveitis in patients with initial acute-onset Vogt-Koyanagi-Harada (VKH) disease using survival analyses. Methods: Patients who were diagnosed with initial acute-onset VKH disease during 2003-2022 at two university hospitals were included. Recurrent anterior uveitis was defined as the first occurrence of the granulomatous anterior uveitis with anterior chamber cells and flare of 2+ or more by the Standardization of Uveitis Nomenclature (SUN) Working Group grading scheme, after the disappearance of conspicuous uveitis and serous retinal detachment for at least 3 months, regardless of systemic or local treatment. The univariate log-rank test and multivariate Cox regression analyses were performed, including patients' demographic characteristics, underlying diseases, presence of prodromal symptoms, duration of visual symptoms, visual acuity, slit-lamp and fundus findings, and height of serous retinal detachment. The treatment method and response to treatment were also included. Results: The estimated incidence was 39.3% at 10 years. Fifteen of 55 patients (27.3%) had recurrent anterior uveitis during the mean follow-up of 4.5 years. The presence of focal posterior synechiae at the diagnosis increased the risk of recurrent anterior uveitis 6.97-fold compared to the absence of synechiae (95% confidence interval [CI], 2.20-22.11; p < 0.001). Use of systemic high-dose steroid therapy more than 7 days after the development of visual symptoms resulted in a hazard ratio of 4.55 (95% CI, 1.27-16.40; p = 0.020). Conclusions: This study reports the estimated incidence and risk factors of recurrent anterior uveitis in VKH disease from survival analyses. However, because of the retrospective nature of this study, it is hard to confirm the consistency of the medical records regarding risk factors, thus, the presence of focal posterior synechiae can be inconclusive as a risk factor. Further studies are warranted.

키워드

High-dose steroid therapyRecurrent VKH diseaseRisk factorsUveitisUveomeningoencephalitic syndrome

식별자

Scopus EID
2-s2.0-85168958614
KCI
ART002984856